Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: DanZ who wrote (1483)	11/8/1999 1:23:00 PM
From: Hank	Read Replies (2) \| Respond to of 5582

Fact- The AJIC article was pulled because of the pre-release of data. (go re-read the press release if that altzhiemers is kicking in again.) Fact- The pulling of the AJIC article prevented the scientific and medical community from reviewing the methods, data, and conclusions. Fact- The AJIC, like all other scientific journals, provides authors with a list of rules upon submission of an article for publication BEFORE THE ARTICLE IS EVEN ACCEPTED FOR PUBLICATION. Fact- GUMM knew AJIC's rules before the article was approved for publication. Yet, according to their own press release, they pre-released data which directly violated those rules. It is MY OPINION that they did this on purpose. If you want to know specifically what data was pre-released, then why don't you ask your buddies at GUMM? The fact that you don't care about this enough to have already found the answers shows how close minded YOU are. Keep the hype up Dr. Spin. Your kind disgusts me and I can counter your BS all day long.